$44.00
1.88[4.46%]
At close: Apr 29
$44.00
0[0.00%]
After Hours: 4:00PM EDT
Crinetics Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Crinetics Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | PM | CRNX | Q1 | -$0.85 | -$0.81 | — | — | $2.68M | $190.00K | — | — | Get Alert |
02/28/2024 | PM | CRNX | Q4 | -$0.84 | -$0.86 | -$0.90 | -4.65% | $709.00K | $260.00K | $0.00 | -100.00% | Get Alert |
11/07/2023 | PM | CRNX | Q3 | -$0.78 | -$0.91 | -$1.01 | -10.99% | $458.00K | $120.00K | $346.00K | 188.33% | Get Alert |
08/08/2023 | AM | CRNX | Q2 | -$0.81 | -$0.86 | -$0.94 | -9.30% | $439.00K | $560.00K | $988.00K | 76.43% | Get Alert |
05/04/2023 | PM | CRNX | Q1 | -$0.73 | -$0.82 | -$0.85 | -3.66% | $3.13M | $300.00K | $2.68M | 793.00% | Get Alert |
02/28/2023 | PM | CRNX | Q4 | -$0.68 | -$0.82 | -$0.84 | -2.44% | $1.08M | $250.00K | $709.00K | 183.60% | Get Alert |
11/14/2022 | AM | CRNX | Q3 | -$0.73 | -$0.83 | -$0.78 | 6.02% | $0.00 | $170.00K | $458.00K | 169.41% | Get Alert |
08/12/2022 | AM | CRNX | Q2 | -$0.70 | -$0.67 | -$0.81 | -20.90% | $0.00 | $600.00K | $439.00K | -26.83% | Get Alert |
05/12/2022 | PM | CRNX | Q1 | -$0.69 | -$0.58 | -$0.73 | -25.86% | $0.00 | — | $3.13M | — | Get Alert |
03/30/2022 | PM | CRNX | Q4 | -$0.66 | -$0.62 | -$0.68 | -9.68% | $0.00 | — | $1.08M | — | Get Alert |
11/05/2021 | AM | CRNX | Q3 | -$0.56 | -$0.70 | -$0.73 | -4.29% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2021 | PM | CRNX | Q2 | -$0.53 | -$0.61 | -$0.70 | -14.75% | $0.00 | — | $0.00 | — | Get Alert |
05/06/2021 | PM | CRNX | Q1 | -$0.71 | -$0.66 | -$0.69 | -4.55% | $71.00K | — | $0.00 | — | Get Alert |
03/30/2021 | PM | CRNX | Q4 | -$0.60 | -$0.58 | -$0.66 | -13.79% | $321.00K | — | $0.00 | — | Get Alert |
11/06/2020 | AM | CRNX | Q3 | -$0.60 | -$0.53 | -$0.56 | -5.66% | $505.00K | — | $0.00 | — | Get Alert |
08/07/2020 | AM | CRNX | Q2 | -$0.51 | — | -$0.53 | — | $0.00 | — | $0.00 | — | Get Alert |
05/08/2020 | AM | CRNX | Q1 | -$0.37 | — | -$0.71 | — | $367.00K | — | $71.00K | — | Get Alert |
03/09/2020 | PM | CRNX | Q4 | -$0.35 | — | -$0.60 | — | $781.00K | — | $321.00K | — | Get Alert |
11/12/2019 | PM | CRNX | Q3 | -$0.38 | — | -$0.60 | — | $548.00K | — | $505.00K | — | Get Alert |
Crinetics Pharmaceuticals (CRNX) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.90, which missed the estimate of $-0.86.
The Actual Revenue was $0K, which missed the estimate of $260K.
Browse earnings estimates, EPS, and revenue on all stocks.